Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG03258 Catequentinib
D12537 Catequentinib hydrochloride
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
PDGFR family
PDGFR
D12537 Catequentinib hydrochloride (USAN)
KIT (CD117)
D12537 Catequentinib hydrochloride (USAN)
FGFR family
FGFR
D12537 Catequentinib hydrochloride (USAN)
VEGFR family
VEGFR1 (FLT1)
D12537 Catequentinib hydrochloride (USAN)
VEGFR2 (KDR)
D12537 Catequentinib hydrochloride (USAN)
VEGFR3 (FLT4)
D12537 Catequentinib hydrochloride (USAN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12537
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12537
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG03258 Catequentinib